News Roche Reports the US FDA’s Approval of Ocrevus Zunovo for Treating Relapse and Progressive Multiple Sclerosis ByDipanshu DixitSeptember 13, 20240Comments
News Eli Lilly’s Ebglyss (Lebrikizumab-lbkz) Receives the US FDA’s Approval for Treating Moderate-to-Severe Atopic Dermatitis ByDipanshu DixitSeptember 13, 20240Comments
News Roche’s Tecentriq Hybreza Receives the US FDA’s Approval for Cancer Treatment ByDipanshu DixitSeptember 13, 20240Comments
VIEWPOINTS Fingers Crossed: Christophe Piketty from Galderma in a Stimulating Conversation with PharmaShotsBySaurabh ChaubeySeptember 11, 20240Comments
INSIGHTS+ Insights+: The US FDA New Drug Approvals in August 2024ByDipanshu DixitSeptember 10, 20240Comments
THOUGHTSPOT Advances in Reproductive Medicine: How Technology is Shaping Donor SelectionByIgor ZagradaninSeptember 10, 20240Comments
VIEWPOINTS Unlocking Innovation: Hjalte Hojsgaard from Insulet Corporation in Dialogue Exchange with PharmaShotsBySaurabh ChaubeySeptember 9, 20240Comments
